Mode
Text Size
Log in / Sign up

Meta-analysis links facial palsy and ANCA negativity to poor hearing in OMAAV patients

Meta-analysis links facial palsy and ANCA negativity to poor hearing in OMAAV patients
Photo by engin akyurt / Unsplash
Key Takeaway
Note that facial palsy and ANCA negativity associate with poor hearing in OMAAV.

This systematic review and meta-analysis examines hearing outcomes in patients with otitis media associated with ANCA-associated vasculitis. The analysis pooled data from four studies, comprising one retrospective cohort study and three case-control studies. The setting for these studies was not reported. The primary outcome measured was hearing status.

The analysis identified significant associations between specific clinical features and poor hearing prognosis. Facial palsy showed an odds ratio of 1.51 with a 95% CI of 1.07-2.15 and a p-value of .02. Hypertrophic pachymeningitis was associated with an odds ratio of 1.73 (95% CI 1.18-2.53; p = .005). ANCA negativity demonstrated an odds ratio of 1.75 (95% CI 1.11-2.77; p = .02).

In contrast, the period from onset to diagnosis was not significantly associated with poor hearing outcomes. The effect size was reported as SEM ± SD 2.54 with a 95% CI of -1.56 to 6.64 and a p-value of .22. Absolute numbers for these outcomes were not reported. Safety data, adverse events, and tolerability were not reported in the included studies.

The authors note that these findings provide diagnosis and treatment guidance in protecting patients' hearing. However, the study design limits causal inference. The certainty of the evidence was not reported. These results highlight specific clinical markers that may warrant closer monitoring for hearing impairment in this population.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
To conduct a systematic review and meta-analysis of clinical studies describing the possible prognostic factors affecting hearing outcomes in Otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) patients. To provide guidance for clinical work, avoiding profound irreversible hearing loss affecting patients' lives. A literature search was performed in PubMed, MEDLINE, EMBASE, Cochrane, Scopus, and Web of Science to identify English articles published before December 1, 2022. After screening the articles, the Newcastle-Ottawa Scale (NOS) was used to assess the risk of bias of the extracted literature, and studies with high quality (score > 6) were included. Four studies were included: 1 was a retrospective cohort study, and 3 were case-control studies. We performed a meta-analysis of 4 factors: facial palsy, hypertrophic pachymeningitis, ANCA-negative status, and the period from onset to diagnosis. The results showed that there was a significant association between facial palsy [odds ratio (OR) 1.51; 95% confidence interval (CI) 1.07-2.15; = 0%; = .02], hypertrophic pachymeningitis (OR 1.73; 95% CI 1.18-2.53; = 24%; = .005), ANCA negativity (OR 1.75; 95% CI 1.11-2.77; = 33; = .02), and poor hearing prognosis in OMAAV patients. However, the period from onset to diagnosis (SEM ± SD 2.54; 95% CI -1.56 to 6.64; = 98%; = .22) of OMAAV was not significantly associated with poor hearing outcomes. We found that OMAAV patients with facial palsy, hypertrophic pachymeningitis, and ANCA negativity have a significant association with poor hearing prognosis, which provides diagnosis and treatment guidance in protecting patients' hearing.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.